Sevoflurane ameliorates gas exchange and attenuates lung damage in experimental lipopolysaccharide-induced lung injury. 2009

Stefanie Voigtsberger, and Robert A Lachmann, and Anik C Leutert, and Martin Schläpfer, and Christa Booy, and Livia Reyes, and Martin Urner, and Julia Schild, and Ralph C Schimmer, and Beatrice Beck-Schimmer
Institute of Anesthesiology, University of Zurich, Zurich, Switzerland.

BACKGROUND Acute lung injury is a common complication in critically ill patients. Several studies suggest that volatile anesthetics have immunomodulating effects. The aim of the current study was to assess possible postconditioning with sevoflurane in an in vivo model of endotoxin-induced lung injury. METHODS Rats were anesthetized, tracheotomized, and mechanically ventilated. Lipopolysaccharide (saline as control) was administered intratracheally. Upon injury after 2 h of propofol anesthesia, general anesthesia was continued with either sevoflurane or propofol for 4 h. Arterial blood gases were measured every 2 h. After 6 h of injury, bronchoalveolar lavage was performed and lungs were collected. Total cell count, albumin content, concentrations of the cytokines cytokine-induced neutrophil chemoattractant-1 and monocyte chemoattractant protein-1, and phospholipids were analyzed in bronchoalveolar lavage fluid. Expression of messenger RNA for the two cytokines and for surfactant protein B was determined in lung tissue. Histopathologic examination of the lung was performed. RESULTS Significant improvement of the ratio of oxygen tension to inspired oxygen fraction was shown with sevoflurane (mean + or - SD: 243 + or - 94 mmHg [32.4 kPa]) compared with propofol (88 + or - 19 mmHg [11.7 kPa]). Total cell count representing effector cell recruitment as well as albumin content as a measure of lung permeability were significantly decreased in the sevoflurane-lipopolysaccharide group compared with the propofol-lipopolysaccharide group in bronchoalveolar lavage fluid. Expression of the cytokines protein in bronchoalveolar lavage fluid as well as messenger RNA in lung tissue was significantly lower in the sevoflurane-lipopolysaccharide group compared with the propofol-lipopolysaccharide group. CONCLUSIONS Postconditioning with sevoflurane attenuates lung damage and preserves lung function in an in vivo model of acute lung injury.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008171 Lung Diseases Pathological processes involving any part of the LUNG. Pulmonary Diseases,Disease, Pulmonary,Diseases, Pulmonary,Pulmonary Disease,Disease, Lung,Diseases, Lung,Lung Disease
D008297 Male Males
D008738 Methyl Ethers A group of compounds that contain the general formula R-OCH3. Ethers, Methyl
D010539 Permeability Property of membranes and other structures to permit passage of light, heat, gases, liquids, metabolites, and mineral ions. Permeabilities
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D011651 Pulmonary Artery The short wide vessel arising from the conus arteriosus of the right ventricle and conveying unaerated blood to the lungs. Arteries, Pulmonary,Artery, Pulmonary,Pulmonary Arteries
D011659 Pulmonary Gas Exchange The exchange of OXYGEN and CARBON DIOXIDE between alveolar air and pulmonary capillary blood that occurs across the BLOOD-AIR BARRIER. Exchange, Pulmonary Gas,Gas Exchange, Pulmonary
D011663 Pulmonary Surfactants Substances and drugs that lower the SURFACE TENSION of the mucoid layer lining the PULMONARY ALVEOLI. Surfactants, Pulmonary,Pulmonary Surfactant,Surfactant, Pulmonary
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic

Related Publications

Stefanie Voigtsberger, and Robert A Lachmann, and Anik C Leutert, and Martin Schläpfer, and Christa Booy, and Livia Reyes, and Martin Urner, and Julia Schild, and Ralph C Schimmer, and Beatrice Beck-Schimmer
February 2009, Clinical and experimental immunology,
Stefanie Voigtsberger, and Robert A Lachmann, and Anik C Leutert, and Martin Schläpfer, and Christa Booy, and Livia Reyes, and Martin Urner, and Julia Schild, and Ralph C Schimmer, and Beatrice Beck-Schimmer
May 2010, International immunopharmacology,
Stefanie Voigtsberger, and Robert A Lachmann, and Anik C Leutert, and Martin Schläpfer, and Christa Booy, and Livia Reyes, and Martin Urner, and Julia Schild, and Ralph C Schimmer, and Beatrice Beck-Schimmer
August 2016, Fundamental & clinical pharmacology,
Stefanie Voigtsberger, and Robert A Lachmann, and Anik C Leutert, and Martin Schläpfer, and Christa Booy, and Livia Reyes, and Martin Urner, and Julia Schild, and Ralph C Schimmer, and Beatrice Beck-Schimmer
June 2009, Nutrition (Burbank, Los Angeles County, Calif.),
Stefanie Voigtsberger, and Robert A Lachmann, and Anik C Leutert, and Martin Schläpfer, and Christa Booy, and Livia Reyes, and Martin Urner, and Julia Schild, and Ralph C Schimmer, and Beatrice Beck-Schimmer
January 2015, Toxicology mechanisms and methods,
Stefanie Voigtsberger, and Robert A Lachmann, and Anik C Leutert, and Martin Schläpfer, and Christa Booy, and Livia Reyes, and Martin Urner, and Julia Schild, and Ralph C Schimmer, and Beatrice Beck-Schimmer
March 2015, European journal of pharmacology,
Stefanie Voigtsberger, and Robert A Lachmann, and Anik C Leutert, and Martin Schläpfer, and Christa Booy, and Livia Reyes, and Martin Urner, and Julia Schild, and Ralph C Schimmer, and Beatrice Beck-Schimmer
June 2011, Toxicology and applied pharmacology,
Stefanie Voigtsberger, and Robert A Lachmann, and Anik C Leutert, and Martin Schläpfer, and Christa Booy, and Livia Reyes, and Martin Urner, and Julia Schild, and Ralph C Schimmer, and Beatrice Beck-Schimmer
December 2013, European journal of medical research,
Stefanie Voigtsberger, and Robert A Lachmann, and Anik C Leutert, and Martin Schläpfer, and Christa Booy, and Livia Reyes, and Martin Urner, and Julia Schild, and Ralph C Schimmer, and Beatrice Beck-Schimmer
August 2007, American journal of physiology. Lung cellular and molecular physiology,
Stefanie Voigtsberger, and Robert A Lachmann, and Anik C Leutert, and Martin Schläpfer, and Christa Booy, and Livia Reyes, and Martin Urner, and Julia Schild, and Ralph C Schimmer, and Beatrice Beck-Schimmer
December 2014, Inflammation,
Copied contents to your clipboard!